These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17685738)

  • 1. Outcome following clozapine discontinuation: a retrospective analysis.
    Atkinson JM; Douglas-Hall P; Fischetti C; Sparshatt A; Taylor DM
    J Clin Psychiatry; 2007 Jul; 68(7):1027-30. PubMed ID: 17685738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life after clozapine.
    Baker M; White T
    Med Sci Law; 2004 Jul; 44(3):217-21. PubMed ID: 15296245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of smoking cessation on psychiatric inpatients treated with clozapine or olanzapine.
    Cole ML; Trigoboff E; Demler TL; Opler LA
    J Psychiatr Pract; 2010 Mar; 16(2):75-81. PubMed ID: 20511731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with changes in hospitalisation in patients prescribed clozapine.
    Gee SH; Shergill SS; Taylor DM
    J Psychopharmacol; 2016 Aug; 30(8):819-25. PubMed ID: 27097730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J
    BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic predictors for mortality among patients treated with long-term clozapine - A longitudinal study.
    Taub S; Hoshen M; Balicer R; Kamhi-Nesher S; Weizman A; Krivoy A
    Eur Neuropsychopharmacol; 2020 Dec; 41():63-69. PubMed ID: 32981820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection.
    Taylor DM; Douglas-Hall P; Olofinjana B; Whiskey E; Thomas A
    Br J Psychiatry; 2009 Feb; 194(2):165-7. PubMed ID: 19182180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
    Legge SE; Hamshere M; Hayes RD; Downs J; O'Donovan MC; Owen MJ; Walters JTR; MacCabe JH
    Schizophr Res; 2016 Jul; 174(1-3):113-119. PubMed ID: 27211516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of clozapine: a 15-year naturalistic retrospective study of 320 patients.
    Davis MC; Fuller MA; Strauss ME; Konicki PE; Jaskiw GE
    Acta Psychiatr Scand; 2014 Jul; 130(1):30-9. PubMed ID: 24299466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia.
    Pridan S; Swartz M; Baruch Y; Tadger S; Plopski I; Barak Y
    Int Psychogeriatr; 2015 Jan; 27(1):131-4. PubMed ID: 25166892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study.
    Miodownik C; Lerner V; Kibari A; Toder D; Cohen H
    J Clin Psychiatry; 2006 Aug; 67(8):1204-8. PubMed ID: 16965197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does therapeutic equivalence follow bioequivalence? A randomized trial to assess clinical effects after switching from Clozaril to generic clozapine (gen-clozapine).
    Oluboka O; Stewart S; Landry S; Adams S
    J Clin Pharmacol; 2010 May; 50(5):531-5. PubMed ID: 20089825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroconvulsive therapy and clozapine in adolescents with schizophrenia spectrum disorders: is it a safe and effective combination?
    Flamarique I; Castro-Fornieles J; Garrido JM; de la Serna E; Pons A; Bernardo M; Baeza I
    J Clin Psychopharmacol; 2012 Dec; 32(6):756-66. PubMed ID: 23131877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Investigation of Clozapine Treatment in Autistic and Nonautistic Children and Adolescents in an Inpatient Clinic in Turkey.
    Yalcin O; Kaymak G; Erdogan A; Tanidir C; Karacetin G; Kilicoglu AG; Mutlu C; Adaletli H; Gunes H; Bahali K; Ayik B; Uneri OS
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):815-821. PubMed ID: 26771824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of clozapine discontinuation in patients with schizophrenia.
    Krivoy A; Malka L; Fischel T; Weizman A; Valevski A
    Int Clin Psychopharmacol; 2011 Nov; 26(6):311-5. PubMed ID: 21849905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidone.
    Still DJ; Dorson PG; Crismon ML; Pousson C
    Psychiatr Serv; 1996 Dec; 47(12):1382-4. PubMed ID: 9117479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation of Treatment With Clozapine After an Episode of Neutropenia.
    Tirupati S; Gordon T
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):320-322. PubMed ID: 33657071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service.
    Inada K; Oshibuchi H; Ishigooka J; Nishimura K
    J Clin Psychopharmacol; 2018 Aug; 38(4):302-306. PubMed ID: 29912802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and characteristics of clozapine- induced fever in a local psychiatric unit in Hong Kong.
    Pui-yin Chung J; Shiu-yin Chong C; Chung KF; Lai-wah Dunn E; Wai-nang Tang O; Chan WF
    Can J Psychiatry; 2008 Dec; 53(12):857-62. PubMed ID: 19087484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.
    Sultan RS; Olfson M; Correll CU; Duncan EJ
    J Clin Psychiatry; 2017; 78(8):e933-e939. PubMed ID: 28742291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.